Navigation Links
VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results
Date:2/19/2013

ROCHESTER, N.Y., Feb. 19, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ:   VSCP), a leading provider of quantitative imaging, today announced revenues of $12,963,164 for the year ended December 31, 2012 compared to $14,281,603 for the year ended December 31, 2011. Net loss for the twelve months ended December 31, 2012 was $1,528,652 compared to a net income of $703,295 for the twelve months ended December 31, 2011.

Other full-year 2012 results include:

  • Approximately $550,000 in investments made within its Personalized Medicine initiative, expenses included within research and development and general and administrative costs in 2012.
  • Gross margin of 41% compared to 44% for the full year of 2011.
  • Research and development expenditures of $1,524,721, representing a $200,258, or 15%, increase compared to prior year.
  • Earnings/(Loss) before interest, taxes, depreciation and amortization, and excluding stock compensation expense and gain/loss from derivative financial instrument ("Adjusted EBITDA") of ($207,512) for the year ended December 31, 2012 compared to Adjusted EBITDA of $1,407,118 for the comparable period in 2011.
  • Excluding investments made within the personalized medicine initiative, full-year Adjusted EBITDA of approximately $340,000.
  • Cash balance of $8,523,807 compared to $5,737,009 as of December 31, 2011.
  • Fourth quarter ended December 31, 2012 results were:

  • Revenues of $2,596,928 compared to $3,500,892 in the fourth quarter of 2011.
  • Gross margin of 40% compared to 39% in the fourth quarter of 2011.
  • Operating loss of $804,300 compared to a loss of $141,747 in the fourth quarter of 2011. Excluding investments made in personalized medicine, operating loss of $432,730.
  • Adjusted EBITDA loss of ($554,635) compared to $183,271 for the fourth quarter of 2011. Excluding investments made in personalized medicine, Adjusted EBITDA of ($183,065)
    '/>"/>

  • SOURCE VirtualScopics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
    2. VirtualScopics Reports 2nd Quarter 2012 Results
    3. VirtualScopics Announces Receipt of Notice from Nasdaq
    4. VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
    5. VirtualScopics Receives Issuance of Influential Patent in Canada
    6. VirtualScopics Reports 3rd Quarter 2012 Results
    7. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
    8. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    9. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    10. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    11. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/19/2014)... , Aug. 19, 2014  Sequence, Inc., an industry leader ... biotech and medical device manufacturers is opening a third office ... Louis , as a result of demand by clients ... which opened this month, allows Sequence to better serve new ... St. Louis office provides Sequence a ...
    (Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
    (Date:8/18/2014)... HERZLIYA-PITUACH, Israel , Aug. 19, 2014 /PRNewswire/ ... Premier, Stockholm : "IMNP"), a biotechnology company, ... to list its common stock on the NASDAQ Capital Market ... of the NASDAQ OMX Group. IMMUNE,s common stock is expected ... opening of trading on August 21, 2014 under the symbol ...
    Breaking Medicine Technology:Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4
    ... Laser,Centers, the largest provider of laser hair removal ... the addition of the VelaShape,cellulite reduction and body ... 30 additional locations before the end of March, ... FDA-approved for both cellulite,reduction and circumferential reduction of ...
    ... has,received its third $10 million tranche of equity funding ... milestones:,validating the efficacy and safety of its two topical ... influenza vaccine in,ferret studies., The company, a spin-off ... $30 million over the past 18 months from Perseus ...
    Cached Medicine Technology:American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment 2NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones 2
    (Date:8/19/2014)... LunaDress, a popular supplier of fashionable ... ladies, is now providing a discount of up to ... company’s cheap white prom outfits are available in different ... outfits. , There are over 400 cheap white ... the special offer is valid until August 29, 2014. ...
    (Date:8/19/2014)... (PRWEB) August 20, 2014 Recently, iFitDress.com,a ... occasion outfits, has unveiled its new collection of ... made to expand the company’s global market. Each item ... to the company’s senior spokesman, customers that have specific ... at iFitDress.com. Now, all the brand new items are ...
    (Date:8/19/2014)... 2014 The National Cannabis Industry ... Southwest CannaBusiness Symposium on Saturday, August 23, from ... in Las Vegas. , Featuring keynotes by U.S. Representative ... (D-Las Vegas), the event will also include in-depth discussions ... NCIA is doing federally to advance a legitimate and ...
    (Date:8/19/2014)... Drews Dental Services is proud to announce the recent election ... Maine Dental Association (MDA). After serving on the Executive Board ... been sworn in to his new position. , Dr. Drews ... and being a part of the ADA House of Delegates ... 2015. He plans to advocate for the profession of dentistry ...
    (Date:8/19/2014)... Tara Haelle HealthDay ... -- Kidney injury can be added to the list ... medications often prescribed to treat behavioral symptoms of dementia ... (Seroquel), risperidone (Risperdal) and olanzapine (Zyprexa) are approved by ... disorder, schizophrenia and other serious mental disorders. They are ...
    Breaking Medicine News(10 mins):Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2Health News:Discounted Pewter Evening Dresses For 2014 Unveiled By Company iFitDress.com 2Health News:SATURDAY IN LAS VEGAS: U.S. Rep. Dina Titus, State Sen. Tick Segerblom Keynote National Cannabis Industry Association Southwest CannaBusiness Symposium 2Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Certain Antipsychotic Meds Tied to Kidney Problems in Elderly 2Health News:Certain Antipsychotic Meds Tied to Kidney Problems in Elderly 3
    ... parents of Canada’s conjoined twins and to the public, who ... of several tests that the twins are growing normally. ... Tatiana Hogan came into the world with their heads joined. ... sleep patterns, vision, hearing and responses to touch. , ...
    ... and type 2 diabetes increases the risk of death for ... of heart disease deaths by itself, but together they’ve been ... an analysis of more than 900 patients with established coronary ... with both type 2 diabetes and symptoms of depression were ...
    ... has titillated the curiosity of investigators, by defying the ... the diagnosis of the disease, is absent in this ... not recognize this new strain, making detection of gonorrhea ... question, playing truant in this odd strain of gonorrhea, ...
    ... in the war against polio, Chief Minster Sheila Dikshit Saturday ... will be immunized Sunday. ,Launching another round of ... of children at her official residence here. ,Delhi ... just one case in 2005. ,'The only threat ...
    ... presented today shows angioplasty and stenting can prevent amputation ... patients// with severe critical limb ischemia and gangrene (tissue ... knee remained open, with a ninety-one percent success rate, ... all patients who were consecutively enrolled over a six-year ...
    ... as well kick the butt. There will be no escape into ... be- released bill// of British Columbia hits the public. ... ban smoking in all indoor public spaces as well as in ... any building accessible by the public. , Says Health ...
    Cached Medicine News:Health News:Combination of Depression and Type-2-diabetes Lethal for Heart Patients 2Health News:Multi-Year Data Shows PAD Treatment Prevents Amputation 2
    ... The Awaya stereo test was developed to ... Awaya Stereo test employs the more reliable ... eye. It is not dependent on polarizing spectacles ... first target is an attractive image of a ...
    ... is designed to assist patients with red-green color ... filter cuts off wavelengths shorter than 582 nm ... of their most difficult color distinctions. A color ... determine whether a color is in the longer ...
    Features a twist-on backswitch, with a diffused, cobalt blue light beam....
    Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
    Medicine Products: